Part I that you still need to know. The field of age management medicine continues to grow at a rapid rate, and we only seem to get busier, making it difficult to stay abreast of all the changes. This is why we’ve condensed an inordinate amount of material into 2 1⁄2 days—in fact, there are over 1,300 slides of information.
Objectives: Upon completion of this workshop, the health care
professional will be able to:
new and additional studies not presented in Part I of advanced protocols for more
complex cases beyond Part I.
important issues in the relationship between hormones and cancer: cause or
effect, provocation or protection? Safety and efficacy of estrogen in breast
cancer survivors. What levels of progesterone are best for breast cancer
protection? Which hormones protect against breast cancer?
recommendations for difficult cases presenting with multiple disease processes
and the potential benefits of hormones in preventing and treating CAD, CVD,
literature citing new indications, risks, benefits and complications of
estrogen, progesterone and testosterone therapy and how to avoid those minor
and contrast different dosing strategies for estrogen and progesterone,
including new and specific approaches to these therapies for both oral and
transdermal and the pros and cons of each.
important aspects of the WHI findings: Review comments from the experts that
refute the results and extrapolation of this study to younger women, and other
factors not included in the trials that would change the conclusions.
7. Review a
literature update of hormones including new and different approaches to thyroid
hormone replacement and disease prevention of CVD, hyperlipidemia, and
over 40 articles that demonstrate thyroid replacement does not cause
osteoporosis, even in TSH suppressive doses. Review the data demonstrating the
importance of optimizing T3 levels for CVD protection, lowering cholesterol,
increasing cardiac output, and decreasing SVR.
various new therapies in the treatment for obesity, CFS, fibromyalgia.
the epidemiology of cardiovascular disease and diabetes and the various
treatment strategies as they pertain to medication, diet, exercise, lifestyle
change, nutritional supplements, and non-drug therapies to stop the progression
11. Explore the
role of omega 3 fatty acids, antioxidants, and glucose metabolism and how they
influence insulin, inflammation, disease progression and atherosclerosis.
the strategies for using the new cardiovascular risk markers, inflammation
markers, new lipid parameters, NMR panel, and how to make sense of all the new lipid
the roles of niacin and EFA in diabetes and atherosclerosis along with
alternatives to statins.
the importance of various vitamins, supplements, and red yeast rice for CVD
current screening methods and management strategies of the most common
premenopausal hormone disorder, Polycystic Ovary Syndrome (PCOS).
various testing strategies for PCOS so that you never miss another case.
treatment regimens for hirsutism and hair loss in men and women.
the literature that demonstrates successful treatment of osteoporosis using
hormone replacement therapy, vitamin K, strontium, ipraflavone and not
19. Review the
positives and negatives of BHRT, why and how BHRT doesn’t work, and how to use
EBM to make it work.
current indications, risks and benefits of using cortisol for the treatment of
chronic fatigue. Monitoring CFS and adrenal reserve via the ACTH stimulation
test and saliva testing.
rational approaches for the evaluation of fatigue with emphasis on cellular
hypofunction (receptor site resistance) as it pertains to thyroid hormone and
based on the literature, when to use oral vs. saliva testing to diagnose
adrenal fatigue as well as treatment options for adrenal fatigue.
based on the literature, when not to use saliva testing to monitor hormone
24. Utilize the
knowledge gained to improve patient outcomes in BHRT followed by 100 questions
and answers beyond Part I.
25. Review the
lack of literature support for lowering estrogen in men and the harm of doing
so. Optimal estrogen is just as important as optimal testosterone in both men
26. Review the
literature proving harm when progesterone is used to treat men in spite of other
academies promoting its use.
27. Review the
harm of using estriol over estradiol in spite of other academies promoting its
that saliva levels correlate well for baseline testing of hormones whereas the
literature shows no correlation with monitoring transdermal replacement of